Alerts will be sent to your verified email
Verify EmailMADHAVBAUG
Vaidya Sane Ayur Lab
|
Gennex Lab
|
Balaxi Pharma.
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
8.39 % | 7.82 % | 27.3 % |
5yr average Equity Multiplier
|
1.34 | 1.53 | 1.4 |
5yr Average Asset Turnover Ratio
|
1.57 | 0.75 | 1.43 |
5yr Avg Net Profit Margin
|
3.83 % | 7.88 % | 11.03 % |
Price to Book
|
0.0 | 1.55 | 1.13 |
P/E
|
39.91 | 17.96 | 13.95 |
5yr Avg Cash Conversion Cycle
|
-76.76 Days | 43.23 Days | 154.28 Days |
Inventory Days
|
11.33 Days | 49.12 Days | 87.41 Days |
Days Receivable
|
24.16 Days | 50.53 Days | 103.86 Days |
Days Payable
|
116.68 Days | 75.36 Days | 63.18 Days |
5yr Average Interest Coverage Ratio
|
6.88 | 6.21 | 57.05 |
5yr Avg ROCE
|
12.91 % | 11.17 % | 36.52 % |
5yr Avg Operating Profit Margin
|
7.94 % | 10.47 % | 16.64 % |
5 yr average Debt to Equity
|
0.02 | 0.18 | 0.09 |
5yr CAGR Net Profit
|
-10.61 % | 43.63 % | -5.76 % |
5yr Average Return on Assets
|
6.19 % | 5.16 % | 18.47 % |
Shareholdings
|
|||
Promoter Holding
|
66.34 % | 19.83 % | 65.99 % |
Share Pledged by Promoters
|
0.0 | 21.79 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | -2.22 % | -6.87 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Vaidya Sane Ayur Lab
|
Gennex Lab
|
Balaxi Pharma.
|
|
---|---|---|---|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
Capex
|
Capex
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|
Segment Wise Break-Up
|
Segment Wise Break-Up
|
-
|
-
|